BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 9360145)

  • 1. Characteristics of an albumin dialysate hemodiafiltration system for the clearance of unconjugated bilirubin.
    Awad SS; Rich PB; Kolla S; Younger JG; Reickert CA; Downing VP; Bartlett RH
    ASAIO J; 1997; 43(5):M745-9. PubMed ID: 9360145
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Can the clearance of tumor necrosis factor alpha and interleukin 6 be enhanced using an albumin dialysate hemodiafiltration system?
    Awad SS; Sawada S; Soldes OS; Rich PB; Klein R; Alarcon WH; Wang SC; Bartlett RH
    ASAIO J; 1999; 45(1):47-9. PubMed ID: 9952006
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Results of a phase I trial evaluating a liver support device utilizing albumin dialysis.
    Awad SS; Swaniker F; Magee J; Punch J; Bartlett RH
    Surgery; 2001 Aug; 130(2):354-62. PubMed ID: 11490371
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Modification of continuous venovenous hemodiafiltration with single-pass albumin dialysate allows for removal of serum bilirubin.
    Chawla LS; Georgescu F; Abell B; Seneff MG; Kimmel PL
    Am J Kidney Dis; 2005 Mar; 45(3):e51-6. PubMed ID: 15754264
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Enhanced clearance of highly protein-bound drugs by albumin-supplemented dialysate during modeled continuous hemodialysis.
    Churchwell MD; Pasko DA; Smoyer WE; Mueller BA
    Nephrol Dial Transplant; 2009 Jan; 24(1):231-8. PubMed ID: 18723569
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Continuous veno-venous single-pass albumin hemodiafiltration in children with acute liver failure.
    Ringe H; Varnholt V; Zimmering M; Luck W; Gratopp A; König K; Reich S; Sauer IM; Gaedicke G; Querfeld U
    Pediatr Crit Care Med; 2011 May; 12(3):257-64. PubMed ID: 20921923
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Albumin dialysis molecular adsorbents recirculating system: impact of dialysate albumin concentration on detoxification efficacy.
    Drexler K; Baustian C; Richter G; Ludwig J; Ramlow W; Mitzner S
    Ther Apher Dial; 2009 Oct; 13(5):393-8. PubMed ID: 19788455
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A new procedure for the removal of protein bound drugs and toxins.
    Stange J; Mitzner S; Ramlow W; Gliesche T; Hickstein H; Schmidt R
    ASAIO J; 1993; 39(3):M621-5. PubMed ID: 8268613
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Principles of bound solute dialysis.
    Patzer J
    Ther Apher Dial; 2006 Apr; 10(2):118-24. PubMed ID: 16684212
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Validity of internal filtration-enhanced hemodialysis as a new hemodiafiltration therapy.
    Mineshima M; Ishimori I; Sakiyama R
    Blood Purif; 2009; 27(1):33-7. PubMed ID: 19169015
    [TBL] [Abstract][Full Text] [Related]  

  • 11. An albumin-fixed membrane for the removal of protein-bound toxins.
    Ge D; Wu D; Shi W; Ma Y; Tian X; Liang P; Zhang Q
    Biomed Mater; 2006 Sep; 1(3):170-4. PubMed ID: 18458399
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A comparison of solute clearance during continuous hemofiltration, hemodiafiltration, and hemodialysis using a polysulfone hemofilter.
    Reeves JH; Butt WW
    ASAIO J; 1995; 41(1):100-4. PubMed ID: 7727810
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of treatment with the Molecular Adsorbents Recirculating System on arterial amino acid levels and cerebral amino acid metabolism in patients with hepatic encephalopathy.
    Schmidt LE; Tofteng F; Strauss GI; Larsen FS
    Scand J Gastroenterol; 2004 Oct; 39(10):974-80. PubMed ID: 15513337
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Reduction in beta2-microglobulin with super-flux versus high-flux dialysis membranes: results of a 6-week, randomized, double-blind, crossover trial.
    Pellicano R; Polkinghorne KR; Kerr PG
    Am J Kidney Dis; 2008 Jul; 52(1):93-101. PubMed ID: 18423807
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Extracorporeal blood detoxification by sorbents in treatment of hepatic encephalopathy.
    Ash SR
    Adv Ren Replace Ther; 2002 Jan; 9(1):3-18. PubMed ID: 11927902
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Efficiency of dialysis with albumin in the treatment of patients with advanced hepatic insufficiency: initial experience with the MARS system in Spain].
    Avilés J; Macía M; Morales S; Pérez F; Moreno A; Navarro J; Navazo L; García J
    Nefrologia; 2001; 21(4):376-85. PubMed ID: 11816514
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Heat stroke with multiple organ failure treated with cold hemodialysis and cold continuous hemodiafiltration: a case report.
    Wakino S; Hori S; Mimura T; Fujishima S; Hayashi K; Inamoto H; Saruta T; Aikawa N
    Ther Apher Dial; 2005 Oct; 9(5):423-8. PubMed ID: 16202019
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In vitro comparison of the molecular adsorbent recirculation system (MARS) and single-pass albumin dialysis (SPAD).
    Sauer IM; Goetz M; Steffen I; Walter G; Kehr DC; Schwartlander R; Hwang YJ; Pascher A; Gerlach JC; Neuhaus P
    Hepatology; 2004 May; 39(5):1408-14. PubMed ID: 15122770
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Severe carbamazepine intoxication unresponsive to albumin-enhanced continuous venovenous hemodiafiltration with low dialysate flow.
    Chung YK; Chang KY; Park HS; Kim MH; Lee KM; Lim TS; Kim HW
    Hemodial Int; 2014 Apr; 18(2):551-5. PubMed ID: 24422855
    [TBL] [Abstract][Full Text] [Related]  

  • 20. pO2 and pCO2 increment in post-dialyzer blood: the role of dialysate.
    Sombolos KI; Bamichas GI; Christidou FN; Gionanlis LD; Karagianni AC; Anagnostopoulos TC; Natse TA
    Artif Organs; 2005 Nov; 29(11):892-8. PubMed ID: 16266303
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.